Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma.

Hematology (Amsterdam, Netherlands)

Avilés A, Talavera A, Díaz-Maqueo JC, Cleto S, Díaz NR, García EL.
PMID: 27416532
Hematology. 1998;3(3):229-33. doi: 10.1080/10245332.1998.11746395.

UNLABELLED: The aim of the present study was to evaluate an intensive chemotherapy regimen in patients with poor prognosis malignant lymphoma. Sixty previously untreated patients with malignant lymphoma of high- or high-intermediate risk were treated with an intensive regimen....

Cite
Avilés A, Talavera A, Díaz-Maqueo JC, et al. High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma. Hematology. 1998;3(3):229-33doi: 10.1080/10245332.1998.11746395.
Avilés, A., Talavera, A., Díaz-Maqueo, J. C., Cleto, S., Díaz, N. R., & García, E. L. (1998). High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma. Hematology (Amsterdam, Netherlands), 3(3), 229-33. https://doi.org/10.1080/10245332.1998.11746395
Avilés, A, et al. "High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma." Hematology (Amsterdam, Netherlands) vol. 3,3 (1998): 229-33. doi: https://doi.org/10.1080/10245332.1998.11746395
Avilés A, Talavera A, Díaz-Maqueo JC, Cleto S, Díaz NR, García EL. High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma. Hematology. 1998;3(3):229-33. doi: 10.1080/10245332.1998.11746395. PMID: 27416532.
Copy Download .nbib Format: NLM
Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?.

Leukemia & lymphoma

Avilés A, Díaz-Maqueo JC, de la Torre A, Rodriguez L, Guzmán R, Talavera A, García EL.
PMID: 27463347
Leuk Lymphoma. 1991;5(5):365-9. doi: 10.3109/10428199109067630.

Fifty-two patients with primary gastric lymphoma were randomly assigned to two different surgical approaches. Twenty-eight cases were diagnosed by endoscopy and treated with chemotherapy CHOP-Bleo (cyclophosphamide, adriamycin, vincristine, prednisone and bleomycin) alternating with CMED (cyclophosphamide, metothexate, etoposide and dexamethasone)....

Cite
Avilés A, Díaz-Maqueo JC, de la Torre A, et al. Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?. Leuk Lymphoma. 1991;5(5):365-9doi: 10.3109/10428199109067630.
Avilés, A., Díaz-Maqueo, J. C., de la Torre, A., Rodriguez, L., Guzmán, R., Talavera, A., & García, E. L. (1991). Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?. Leukemia & lymphoma, 5(5), 365-9. https://doi.org/10.3109/10428199109067630
Avilés, A, et al. "Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?." Leukemia & lymphoma vol. 5,5 (1991): 365-9. doi: https://doi.org/10.3109/10428199109067630
Avilés A, Díaz-Maqueo JC, de la Torre A, Rodriguez L, Guzmán R, Talavera A, García EL. Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?. Leuk Lymphoma. 1991;5(5):365-9. doi: 10.3109/10428199109067630. PMID: 27463347.
Copy Download .nbib Format: NLM
Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma.

Hematology (Amsterdam, Netherlands)

Avilés A, Díaz-Maqueo JC, Talavera A, García EL, Nambo MJ.
PMID: 27414082
Hematology. 1998;3(5):381-6. doi: 10.1080/10245332.1998.11746412.

To assess the efficacy and toxicity of interferon alfa 2b (IFN) as maintenance therapy in patients with malignant lymphoma on complete response after conventional chemotherapy we start a randomized clinical trial. One hundred and seventy patients were randomized to...

Cite
Avilés A, Díaz-Maqueo JC, Talavera A, et al. Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma. Hematology. 1998;3(5):381-6doi: 10.1080/10245332.1998.11746412.
Avilés, A., Díaz-Maqueo, J. C., Talavera, A., García, E. L., & Nambo, M. J. (1998). Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma. Hematology (Amsterdam, Netherlands), 3(5), 381-6. https://doi.org/10.1080/10245332.1998.11746412
Avilés, A, et al. "Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma." Hematology (Amsterdam, Netherlands) vol. 3,5 (1998): 381-6. doi: https://doi.org/10.1080/10245332.1998.11746412
Avilés A, Díaz-Maqueo JC, Talavera A, García EL, Nambo MJ. Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma. Hematology. 1998;3(5):381-6. doi: 10.1080/10245332.1998.11746412. PMID: 27414082.
Copy Download .nbib Format: NLM
Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease.

Hematology (Amsterdam, Netherlands)

Avilés A, Delgado S, Talavera A, González JL, Díaz Maqueo JC.
PMID: 11399590
Hematology. 2000;4(6):479-485.

To determine if the use of adjuvant radiotherapy to sites of initial bulky disease and adequate modern chemotherapy in patients with advanced stages (IIIB and IV) Hodgkin's disease could improve duration of remission and overall survival. Patients previously untreated...

Cite
Avilés A, Delgado S, Talavera A, et al. Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease. Hematology. 2000;4(6):479-485
Avilés, A., Delgado, S., Talavera, A., González, J. L., & Díaz Maqueo, J. C. (2000). Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease. Hematology (Amsterdam, Netherlands), 4(6), 479-485.
Avilés, AGUSTIN, et al. "Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease." Hematology (Amsterdam, Netherlands) vol. 4,6 (2000): 479-485.
Avilés A, Delgado S, Talavera A, González JL, Díaz Maqueo JC. Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease. Hematology. 2000;4(6):479-485. PMID: 11399590.
Copy Download .nbib Format: NLM
Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy.

Hematology (Amsterdam, Netherlands)

Avilés A, García EL, Victoria W, Neri N, Huerta-Guzmán J, Díaz-Maqueo JC.
PMID: 27419346
Hematology. 2001;5(6):435-40. doi: 10.1080/10245332.2001.11746540.

Although complete response (CR) rate has been increased with the use of more intensive and in some cases myeloblative chemotherapy, long term follow-up has shown that relapse continues to be a major problem in patients with diffuse large cell...

Cite
Avilés A, García EL, Victoria W, et al. Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy. Hematology. 2001;5(6):435-40doi: 10.1080/10245332.2001.11746540.
Avilés, A., García, E. L., Victoria, W., Neri, N., Huerta-Guzmán, J., & Díaz-Maqueo, J. C. (2001). Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy. Hematology (Amsterdam, Netherlands), 5(6), 435-40. https://doi.org/10.1080/10245332.2001.11746540
Avilés, A, et al. "Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy." Hematology (Amsterdam, Netherlands) vol. 5,6 (2001): 435-40. doi: https://doi.org/10.1080/10245332.2001.11746540
Avilés A, García EL, Victoria W, Neri N, Huerta-Guzmán J, Díaz-Maqueo JC. Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy. Hematology. 2001;5(6):435-40. doi: 10.1080/10245332.2001.11746540. PMID: 27419346.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries